Preview

Translational Medicine

Advanced search

Immobilized carbon nanotubes as activators of cellular elements of blood in contact interaction

https://doi.org/10.18705/2311-4495-2022-9-5-87-95

Abstract

Background. The use of nanotechnology achievements in medicine opens up prospects for the development and improvement of means and methods of prevention and treatment of diseases of various origins. Carbon nanotubes (CNTs) are a product of modern nanotechnologies, and in addition to their unique physical and chemical properties, they are promising for practical applications in medicine. CNTs are one of the most popular (comparable only with silver and titanium dioxide nanoparticles) objects of nanotoxicological research. Data on the effect of CNTs on blood cells are contradictory, so additional studies are necessary. Objective. To assess the activation capabilities of immobilized carbon nanotubes by the rate of adhesion of blood cell elements to their surface in vitro. Design and methods. Hemocontact interaction was carried out in bench conditions using donor blood in rotational mode. Blood samples were taken before the start of the experiment and after 5, 20, 40 and 60 min. Changes in the indicators of cell blood populations using the hematology analyzer SySmex XT 1800i (26 parameters). 50 experiments were conducted. To analyze the activation functions, a speed-time adhesive profile was used. Results. The highest rates of activation of cellular elements of the blood were recorded in contact with multi-walled carbon nanotubes SiloMUNT. Conclusion. The results of the study can be further implemented in the procedure of low-volume hemoperfusion in clinical practice.

About the Authors

I. G. Grischuk
Almazov National Medical Research Centre
Russian Federation

Ivan G. Grishchuk, laboratory researcher, Research Laboratory of bioprosthetics and cardioprotection, Center for experimental biomodeling, Institute of experimental
medicine

Saint Petersburg



E. E. Sviridov
Almazov National Medical Research Centre; Gemakton Limited Liability Company
Russian Federation

Erik E. Sviridov, student, Medical faculty of the Institute of medical education, laboratory researcher, Research Laboratory of bioprosthetics and cardioprotection, Center for experimental biomodeling, Institute of experimental medicine, Almazov National Medical Centre; general director, Hemacton, Limited Liability Company

Saint Petersburg



S. I. Kuznetsov
Almazov National Medical Research Centre; Gemakton Limited Liability Company
Russian Federation

Sergei I. Kuznetsov, Dr. Sc., Professor, Chief Researcher, Research Laboratory of bioprosthetics and cardioprotection, Center for experimental biomodeling of the Institute of experimental medicine, Almazov National Medical Centre; Research Fellow, Hemacton, Limited Liability Company

Saint Petersburg



D. V. Sorokin
Almazov National Medical Research Centre; Gemakton Limited Liability Company
Russian Federation

Dmitry V. Sorokin, student, Medical faculty of the Institute of medical education, Almazov National Medical Centre; laboratory assistant-researcher, Hemacton, Limited Liability Company

Saint Petersburg



V. A. Znamensky
Almazov National Medical Research Centre; Gemakton Limited Liability Company
Russian Federation

Victor A. Znamensky, student, Medical faculty of the Institute of medical education Almazov National Medical Centre; laboratory assistant-researcher, Hemacton, Limited Liability Company

Saint Petersburg



L. U. Abdullina
Almazov National Medical Research Centre
Russian Federation

Laysan U. Abdullina, student,Medical faculty of the Institute of medical education

Saint Petersburg



M. R. Chubarova
Almazov National Medical Research Centre
Russian Federation

Mariya R. Chubarova, student, Medical faculty of the Institute of medical education

Saint Petersburg



A. D. Kiseleva
Almazov National Medical Research Centre
Russian Federation

Anastasia D. Kiseleva, student, Medical faculty of the Institute of medical education

Saint Petersburg



S. M. Minasyan
Almazov National Medical Research Centre
Russian Federation

Sarkis M. Minasyan, MD, Senior researcher, research Laboratory of Microcirculation and Myocardial Metabolism, Institute of Experimental Medicine

Saint Petersburg



V. N. Postnov
Almazov National Medical Research Centre; Saint Petersburg State University, Saint Petersburg
Russian Federation

Viktor N. Postnov, MD, Senior researcher, research Laboratory of nanotechnologies, Center for experimental biomodeling, Almazov National Medical Centre

Saint Petersburg



N. V. Burkova
Almazov National Medical Research Centre; Gemakton Limited Liability Company
Russian Federation

Natalya V. Burkova, Dr. Sc., Professor, the Department of physiology, Medical faculty of the Institute of medical education, Head of the department of Physiology, Almazov National Medical Centre; Scientific chief, Hemacton, Limited Liability Company

Saint Petersburg



References

1. Baimova YA, Mulyukov RR. Graphene, nanotubes and other carbon nanostructures. Russian Academy of sciences: Moscow. 2018; p.212. In Russian [Баимова Ю.А, Мулюков Р.Р. Графен, нанотрубки и другие углеродные наноструктуры. Российская академия наук: Москва. 2018; с. 212.] DOI: 10.31857/S9785907036369000001.

2. Gmoshinsky IV, Khotimchenko SA, Riger NA, et al. Carbon nanotubes: mechanisms of the action, biological markers and evaluation of the (review of literature). Gig Sanit. 2017; 96(2):176–186. In Russian [Гмошинский И.В., Хотимченко С.А., Ригер Н.А. и др. Углеродные нанотрубки: механизмы действия, биологические маркеры и оценка токсичности in vivo (обзор литературы). Гигиена и санитария. 2017; 96(2):176–186]. DOI: 10.18821/0016-9900-2017-96-2-176-186.

3. Kolesnikov OL, Makarenko ON, Trofimova NV, et al. Investigation of the action of nanotubes on the vitro viability indicators of lymphocytes and neutrophils in vitro. Bulletin of the Ural Medical Academic Science. 2011; 2(2):90–91. In Russian [Колесников О.Л., Макаренко О.Н., Трофимова Н.В. и др. Исследование действия нанотрубок на показатели жизнеспособности лимфоцитов и нейтрофилов in vitro. Вестник Уральской медицинской академической науки. 2011; 2(2):90–91.]

4. Schrand AM, Dai L, Schlager J, Hussain S, et al. Differential biocompatibility of carbon nanotubes and nanodiamonds. Diamond Relat. Mater. 2007; 16(12): 2118– 2123. DOI:10.1016/J.DIAMOND.2007.07.020.

5. Funahashi S, Okazaki Y, Ito D et al. Asbestos and multi-walled carbon nanotubes generate distinct oxidative responses in inflammatory cells. J Clin Biochem Nutr. 2015; 56(2):111–117. DOI: 10.3164/jcbn.14-92.

6. Burkova NV, Kuznetsov SI, Tyukavin AI. Effects of low-volume perfusion of blood activated by hemosorbents. Journal of postgraduate medical education=”Vestnik SantPeterburgskoy Meditsinskoy Academii poslediplomnogo obrazovania”. 2011; 3(4):24–32. In Russian [Буркова Н.В., Кузнецов С.И., Тюкавин А.И. Эффекты малообъемной перфузии крови, активированной гемосорбентами. Вестник Санкт-Петербургской медицинской академии последипломного образования. 2011; 3(4):24–32.]

7. Kirichuk OP, Burkova NV, Romanchuk EV, et al. Valuation of Activation Capabilities of SolidPhase Surfaces by the Rate of Adhesion of Blood Cells. Translational Medicine. 2019; 6(3):53–60. In Russian [Киричук О.П., Буркова Н.В., Романчук Е.В. и др. Оценка активационных возможностей твердофазных поверхностей по скорости адгезии клеток крови. Трансляционная медицина. 2019; 6(3):53–60.] DOI: 10.18705/2311-4495-2019-6-3- 53-60.

8. Kuznetsov SI, Kirichuk OP, Burkova NV, et al. Comparison of the activation capabilities of hemosorbents by adhesion rate of blood cells in vitro. Translational Medicine. 2021; 8(5):57–66. In Russian [Кузнецов С.И., Киричук Щ.П., Буркова Н.В. и др. Сравнение активационных возможностей гемосорбентов по скорости адгезии клеток крови in vitro. Трансляционная медицина. 2021; 8(5):57–66.] DOI: 10.18705/2311-4495-2021-8-5.

9. Postnov VN, Novikov AG, Romanychev AI, et al. Synthesis of carbon nanotubes from a cobalt-containing aerosilogel. Russ J Gen Chem. 2014; 84(5): 962–963. DOI: 10.1134/S1070363214050302.

10.


Review

For citations:


Grischuk I.G., Sviridov E.E., Kuznetsov S.I., Sorokin D.V., Znamensky V.A., Abdullina L.U., Chubarova M.R., Kiseleva A.D., Minasyan S.M., Postnov V.N., Burkova N.V. Immobilized carbon nanotubes as activators of cellular elements of blood in contact interaction. Translational Medicine. 2022;9(5):87-95. (In Russ.) https://doi.org/10.18705/2311-4495-2022-9-5-87-95

Views: 507


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2311-4495 (Print)
ISSN 2410-5155 (Online)